You are viewing the site in preview mode

Skip to main content

Advertisement

Table 1 Characteristics of 138 study participants with known HIV status

From: The burden and treatment of HIV in tuberculosis patients in Papua Province, Indonesia: a prospective observational study

  All HIV+ HIV- p value (HIV+ vs HIV-)
Number (%) 138 18 (13.0) 120 (87.0)  
Age in years: median (range) 27 (15-65) 31 (16-60) 27 (15-56) 1.0
Papuan: no. (%) 67 (48.6) 14 (77.8) 53 (44.2) 0.01
Female: no. (%) 43 (31.2) 7 (38.9) 36 (30.0) 0.4
Current smoker: no.(%) 42 (30.4) 5 (27.8) 37 (30.8) 0.8
Highest educational attainment: no. (%)     
   No schooling 10 (7.2) 4 (22.2) 6 (5.0)  
   Primary school 28 (20.3) 4 (22.2) 24 (20) 0.05*
   High school 96 (69.6) 10 (55.6) 86 (71.7)  
   Academy or university 4 (2.9) 0 (0) 4 (3.3)  
Unemployed: no. (%) 59 (44.7) 12 (66.7) 47 (41.2) 0.04*
Owns telephone: no. (%) 77 (55.8) 8 (44.4) 69 (57.7) 0.3
Clinical and laboratory investigations
BMI in kg/m2: mean (range) 19.3 (12.9-32.5) 19.2 (12.9-26.7) 19.4 (13.3-32.5) 0.8
Percentage of predicted FEV1: mean (range) 63.9 (16.6-108.5) 59.5 (16.5-92.0) 64.6 (23.9-108.5) 0.3
6 minute walk test in m: median (range) 415 (0-612) 390 (0-485) 415 (75-612) 0.04
St George's Respiratory Questionnaire† total score: median (range) 38.3 (5.2 - 91.9) 41.7 (13.6-67.0) 38.1 (5.2-91.9) 0.4
Haemoglobin in g/dL: mean (range) 12.4 (7.1-16.0) 11.2 (8.5-12.9) 12.6 (7.1-16) 0.002
   Anaemia: n (%) 77 (55.8) 14 (77.8) 63 (52.5) 0.053
White cell count × 109/L: mean (range) 8.0 (1.6-22.7) 6.8 (2.4-13.2) 9.0 (1.6-22.7) 0.01
Sputum smear ≥2+: no. (%) 61 (45.2) 5 (27.8) 56 (47.9) 0.1
Chest X-ray     
   Total score: median (IQR) 67 (4-140) 57 (19-121) 68 (6-140) 0.5
   Cavitary disease on CXR: no. (%) 74 (55.2) 6 (33.3) 68 (58.6) 0.04
   Pleural effusion: no. (%) 23 (17.2) 7 (38.9) 16 (13.8) 0.009
  1. *Differences in education and employment were not significant in multivariate models controlling for ethnicity. †St George's Respiratory Questionnaire results were only available in 119 participants (15 HIV+ and 104 HIV-)